-+ 0.00%
-+ 0.00%
-+ 0.00%

Theraclion Wins Saudi Approval for Sonovein Varicose Vein Treatment

PUBT·11/03/2026 17:02:05
Theraclion Wins Saudi Approval for Sonovein Varicose Vein Treatment
  • Theraclion secured Saudi Food and Drug Authority marketing authorization for Sonovein on October 28, 2026.
  • The authorization enables Saudi sales of the noninvasive varicose vein treatment platform through local distributors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theraclion SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202611031200BIZWIRE_USPR_____20261103_BW387443) on November 03, 2026, and is solely responsible for the information contained therein.